henhaobio
Sign in

bioRxivBiochemistry

CRISPR/Cas "non-target" sites inhibit on-target cutting rates

E. A. Moreb, M. Hutmacher, M. D. Lynch

PDFDOIPreprint

Abstract

CRISPR/Cas systems have become ubiquitous for genome editing in eukaryotic as well as bacterial systems. Cas9 associated with a guide RNA (gRNA) searches DNA for a matching sequence (target site) next to a protospacer adjacent motif (PAM) and once found, cuts the DNA. The number of PAM sites in the genome are effectively a non-target pool of inhibitory substrates, competing with the target site for the Cas9/gRNA complex. We demonstrate that increasing the number of non-target sites for a given gRNA reduces on-target activity in a dose dependent manner. Furthermore, we show that the use of Cas9 mutants with increased PAM specificity towards a smaller subset of PAMs (or smaller pool of competitive substrates) improves cutting rates. Decreasing the non-target pool by increasing PAM specificity provides a path towards improving on-target activity for slower high fidelity Cas9 variants. These results demonstrate the importance of competitive non-target sites on Cas9 activity and, in part, may help to explain sequence and context dependent activities of gRNAs. Engineering improved PAM specificity to reduce the competitive non-target pool offers an alternative strategy to engineer Cas9 variants with increased specificity and maintained on-target activity. HighlightsO_LIThe pool of non-target PAM sites inhibit Cas9/gRNA on-target activity C_LIO_LInon-target PAM inhibition is dose dependent C_LIO_LInon-target PAM inhibition is a function of gRNA sequence C_LIO_LInon-target PAM inhibition is a function of Cas9 levels C_LI

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.

Similarity Map
SelectedSame fieldCross-field
THISLegut '20Rose '20O'Geen '15Shi '25Dey '24Klein '17
72% semantic matchBioengineering
M. Legut, Z. Daniloski, X. Xue+4 more·bioRxiv·Jan 22, 2020